Related references
Note: Only part of the references are listed.Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Richard S. Finn et al.
CLINICAL CANCER RESEARCH (2012)
Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis
Kerstin Schuette et al.
DIGESTION (2011)
Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma
Yu-Yun Shao et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular Carcinoma
Yu-Yun Shao et al.
CANCER (2010)
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Fidel-David Huitzil-Melendez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Treatment of Advanced Hepatocellular Carcinoma: Intraarterial Infusion Chemotherapy Combined with Interferon
Hiroaki Nagano
ONCOLOGY (2010)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Is the addition of subcutaneous interferon-α-2b beneficial?
Satoe Takaki-Hamabe et al.
HEPATOLOGY RESEARCH (2009)
Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
Marcus Alexander Wörns et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma in Japan: the J-HCC Guidelines
Norihiro Kokudo et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Commentary: Sorafenib Use in Patients with Advanced Hepatocellular Carcinoma and Underlying Child-Pugh B Cirrhosis-Evidence and Controversy
Andrew X. Zhu et al.
ONCOLOGIST (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma
Jun Yong Park et al.
CANCER (2007)
Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma
Hidenari Nagai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis
JY Cheong et al.
HEPATOLOGY RESEARCH (2005)
Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
T Yamasaki et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Interventional radiology for advanced hepatocellular carcinoma: Comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization
S Sumie et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis - Analysis of 48 cases
E Ando et al.
CANCER (2002)
Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein
T Itamoto et al.
JOURNAL OF SURGICAL ONCOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
